societal pressures for change in the methods of providing health care; a millennium of articles and books have been published on the subject. These pressures for change are having a direct effect on the practice of pharmacy. One of the effects is that our national professional associations are looking into their crystal balls to determine their future organizational direction. The American Society of Hospital Pharmacists long ago established a group of crystal ball gazers to help the Society maintain its avant-garde position in American pharmacy.
The ASHP's Commission on Goals (a group hopefully endowed with clairvoyance) recently made sweeping recommendations for change in the organizational structure and direction of the Society. Since it is impossible to do justice to these recommendations here, I refer readers to the full text printed elsewhere. 1 Recommendations for change of any kind are usually attacked and, the more drastic the change proposed, the more vigorous the attack becomes. The Commission on Goals would like the ASHP to expand its horizon to include pharmacy practice outside the hospital, viz., in all organized health care settings. The APhA and ASHP for years have had difficulty in resolving territorial rights and this proposal certainly inflames that issue. The split between the two organizations, which became official with the APhA's position that the ASHP is no longer to be recognized as an affiliated organization, could rapidly become a chasm as the heat of debate intensifies.
There is no intent here to reach a conclusion as to whether the ASHP's Commission is right or wrong in its wisdom for proposed change. Rather I intend to probe into some of the issues discussed by others. One of the most important points brought out in a discussion of this topic has been that the vast majority of hospitals in the nation do not have a safe and efficient drug distribution system despite the fact that the ASHP has been working toward this end since its founding in 1942 and has intensely supported the concepts of unit dose and intravenous admixture programs for about ten years. Further, it is the desire of many hospital pharmacists to develop clinical services and this is certainly an objective of the ASHP. Looking at the slow progress in improving drug distribution systems, one wonders how rapidly clinical services will develop, or how much progress can be made in any or all of the programs undertaken by hospital pharmacists, if the ASHP enlarges its scope of activities. At issue here is whether the ASHP, as a specialty organization, should embark on expansion into health care settings other than hospitals, when it has not fulfilled its responsibilities to the latter. Certainly it can be argued that a concentrated effort is most effective, and that, organizationally speaking, we have witnessed the difficulty the APhA, the AMA and other associations have had in trying to be all things to all members.
On the other hand, both the APhA and AMA have demonstrated that, by forming subgroups (Academies) within their vast organizations, these specialty groups can effectively concentrate on problems and resolve them. The internal struggles of both the APhA and AMA have been more between than within such specialty groups. Thus, with the growth and expansion of the ASHP, there is to be expected an increased degree of discord between those concerned with one specialized area of interest and those concerned with a different area of involvement.
If the ASHP enlarges its membership by accepting and encouraging those who are not dedicated principally to hospital practice, it could arrive at a position in direct competition with the APhA for a sizable portion of members. The ASHP would have to offer something more to its members and predictably would have to provide an organizational mechanism responsive to the needs of specialty groups within the structure. One such group consists of those members dedicated to clinical pharmacy. At this year's Annual Meeting the ASHP established a Council on Clinical Pharmacy and Therapeutics. How long the council structure will suffice to meet the needs of burgeoning specialty groups is difficult to ascertain. History reveals, however, that when sufficient numbers of men of like interest get together, they will form an organization. Whether clinical pharmacists remain within the established organizational structures, or form a separate organization, depends on the leadership of the APhA and ASHP. The proposal of the ASHP's Commission on Goals may be the pace car for the race that is about to begin. If there is any truth to the adage that opportunity knocks only once, then this may be the appropriate time for the leaders of the ASHP to develop a new organization responsive to both clinical and hospital pharmacists.
This subject should be of great concern to many readers and I invite your comments. Your dialogue will help to further explore and clarify the issues involved in the proposed new objectives of the ASHP. 
